OSL •
Healthcare •
Medical Distribution •
Quote as of 09/08/2026 16:16
Company Profile
IndustryMedical Distribution
SectorHealthcare
ExchangeOSL
Market Capitalization328.54 mln
Float10.94 mln
Earnings Date10/29/2026
Beneish M-Score
-2.8
Likely reliable
1-Year Forecast
21.00
Exceptional upside
Relative Strength
10
/ 100
Significantly lagging
Debt / Equity
0.60
Moderate leverage
Pre-Tax Margin
-3%
Barely loss-making
ROE
-2.95
Negative
Business Description
Navamedic ASA is a Norway-based pharmaceutical company founded in 2002 that develops and sells a broad range of health products across Scandinavia, the Netherlands, and other international markets. Its offering spans prescription and over-the-counter medicines, medical nutrition for rare metabolic conditions, medical devices, and consumer health products such as treatments for pain, digestive issues, and erectile dysfunction. The company also supplies specialist prescription medicines addressing obesity, Parkinson's disease, urology, and cardiology, distributing its full portfolio to hospitals, pharmacies, and patients.
